Sweden · Delayed Price · Currency is SEK Medclair AB Statistics
Total Valuation
Medclair AB has a market cap or net worth of SEK 219.04 million. The enterprise value is 198.66 million.
| Market Cap | 219.04M |
| Enterprise Value | 198.66M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medclair AB has 91.65 million shares outstanding. The number of shares has increased by 22.40% in one year.
| Current Share Class | 91.65M |
| Shares Outstanding | 91.65M |
| Shares Change (YoY) | +22.40% |
| Shares Change (QoQ) | +28.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 43.57.
| PE Ratio | 43.57 |
| Forward PE | n/a |
| PS Ratio | 3.73 |
| PB Ratio | 2.77 |
| P/TBV Ratio | 4.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 44.56 |
| EV / Sales | 3.38 |
| EV / EBITDA | 19.36 |
| EV / EBIT | 36.08 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.85
| Current Ratio | 4.85 |
| Quick Ratio | 2.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 9.32 |
Financial Efficiency
Return on equity (ROE) is 6.75% and return on invested capital (ROIC) is 10.32%.
| Return on Equity (ROE) | 6.75% |
| Return on Assets (ROA) | 4.56% |
| Return on Invested Capital (ROIC) | 10.32% |
| Return on Capital Employed (ROCE) | 6.95% |
| Weighted Average Cost of Capital (WACC) | 8.25% |
| Revenue Per Employee | 3.92M |
| Profits Per Employee | 297,200 |
| Employee Count | 15 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 2.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.54% in the last 52 weeks. The beta is 0.73, so Medclair AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +24.54% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 2.74 |
| Relative Strength Index (RSI) | 47.17 |
| Average Volume (20 Days) | 145,090 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medclair AB had revenue of SEK 58.80 million and earned 4.46 million in profits. Earnings per share was 0.05.
| Revenue | 58.80M |
| Gross Profit | 39.15M |
| Operating Income | 5.51M |
| Pretax Income | 4.46M |
| Net Income | 4.46M |
| EBITDA | 10.26M |
| EBIT | 5.51M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 20.37 million in cash and n/a in debt, with a net cash position of 20.37 million or 0.22 per share.
| Cash & Cash Equivalents | 20.37M |
| Total Debt | n/a |
| Net Cash | 20.37M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 79.17M |
| Book Value Per Share | 0.86 |
| Working Capital | 39.76M |
Cash Flow
In the last 12 months, operating cash flow was -1.11 million and capital expenditures -90,000, giving a free cash flow of -1.20 million.
| Operating Cash Flow | -1.11M |
| Capital Expenditures | -90,000 |
| Depreciation & Amortization | 4.76M |
| Net Borrowing | n/a |
| Free Cash Flow | -1.20M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 66.58%, with operating and profit margins of 9.36% and 7.58%.
| Gross Margin | 66.58% |
| Operating Margin | 9.36% |
| Pretax Margin | 7.58% |
| Profit Margin | 7.58% |
| EBITDA Margin | 17.45% |
| EBIT Margin | 9.36% |
| FCF Margin | n/a |
Dividends & Yields
Medclair AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.40% |
| Shareholder Yield | -22.40% |
| Earnings Yield | 2.04% |
| FCF Yield | -0.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |